Anti-PGRC1/ PGRMC1/ Dap1 monoclonal antibody

Anti-PGRC1/ PGRMC1/ Dap1 antibody for FACS & in-vivo assay

Target products collectionGo to PGRMC1/PGRMC1 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-T17814-Ab-1/ GM-Tg-hg-T17814-Ab-2Anti-Human PGRMC1 monoclonal antibodyHuman
GM-Tg-rg-T17814-Ab-1/ GM-Tg-rg-T17814-Ab-2Anti-Rat PGRMC1 monoclonal antibodyRat
GM-Tg-mg-T17814-Ab-1/ GM-Tg-mg-T17814-Ab-2Anti-Mouse PGRMC1 monoclonal antibodyMouse
GM-Tg-cynog-T17814-Ab-1/ GM-Tg-cynog-T17814-Ab-2Anti-Cynomolgus/ Rhesus macaque PGRMC1 monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-T17814-Ab-1/ GM-Tg-felg-T17814-Ab-2Anti-Feline PGRMC1 monoclonal antibodyFeline
GM-Tg-cang-T17814-Ab-1/ GM-Tg-cang-T17814-Ab-2Anti-Canine PGRMC1 monoclonal antibodyCanine
GM-Tg-bovg-T17814-Ab-1/ GM-Tg-bovg-T17814-Ab-2Anti-Bovine PGRMC1 monoclonal antibodyBovine
GM-Tg-equg-T17814-Ab-1/ GM-Tg-equg-T17814-Ab-2Anti-Equine PGRMC1 monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-T17814-Ab-1/ GM-Tg-hg-T17814-Ab-2; GM-Tg-rg-T17814-Ab-1/ GM-Tg-rg-T17814-Ab-2;
GM-Tg-mg-T17814-Ab-1/ GM-Tg-mg-T17814-Ab-2; GM-Tg-cynog-T17814-Ab-1/ GM-Tg-cynog-T17814-Ab-2;
GM-Tg-felg-T17814-Ab-1/ GM-Tg-felg-T17814-Ab-2; GM-Tg-cang-T17814-Ab-1/ GM-Tg-cang-T17814-Ab-2;
GM-Tg-bovg-T17814-Ab-1/ GM-Tg-bovg-T17814-Ab-2; GM-Tg-equg-T17814-Ab-1/ GM-Tg-equg-T17814-Ab-2
Products NameAnti-PGRMC1 monoclonal antibody
Formatmab
Target NamePGRMC1
Protein Sub-locationTransmembrane Protein
Category of antibodyFACS/Biofunctional Antibody, Therapeutics Target antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by using flow cytometry with antigen overexpressed cell line. The biofunction of antibodies are validated in cell-based assay (IC50 or EC50 TBD).
TagFc
Products descriptionPre-made anti-PGRMC1 benchmark inhibitory monoclonal antibody(mab) (blocking antibody inhibitor) is expressed by mammalian cell line as a benchmark antibody for cell culture, FACS,ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation Lyophilized from sterile PBS, PH 7.4
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenProducts DevelopingMulti-species PGRC1/ PGRMC1/ Dap1 VLP (virus-like particle) (Products Developing)
    ORF Viral VectorvGMLP004673human PGRMC1 Lentivirus particle
    ORF Viral VectorpGMLP004673human PGRMC1 Lentivirus plasmid
    ORF Viral VectorpGMAAV000311Norway rat Pgrmc1 AAV plasmid
    ORF Viral VectorvGMAAV000311Norway rat Pgrmc1 AAV particle


    Target information

    Target IDGM-T17814
    Target NamePGRMC1
    Gene ID10857,53328,291948,711792,481029,105260228,317706,100058718
    Gene Symbol and Synonyms25-Dx,25Dx,Dap1,HPR6.6,IZA,MPR,PGRMC1,PPMR,Vema
    Uniprot AccessionO00264,P70580,Q17QC0
    Uniprot Entry NamePGRC1_HUMAN,PGRC1_RAT,PGRC1_BOVIN
    Protein Sub-locationTransmembrane Protein
    CategoryTherapeutics Target
    DiseaseN/A
    Gene EnsemblENSG00000101856
    Target ClassificationN/A

    The target: PGRMC1, gene name: PGRMC1, also named as Dap1, HPR6.6, IZA, MPR. This gene encodes a putative membrane-associated progesterone steroid receptor. The protein is expressed predominantly in the liver and kidney. [provided by RefSeq, Mar 2010].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.